Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Dr. Reddy's Laboratories

02 1Supriya Lifescience

03 1Naprod Life Sciences

04 2AFT Pharmaceuticals

05 5Accord healthcare

06 1Apotex Inc

07 1Aspiro Pharma

08 1Aurobindo Pharma Limited

09 1Baxter Healthcare Corporation

10 2Biological E

11 1Caplin Point Laboratories Limited

12 1Chia Tai Tianqing Pharmaceutical Group

13 1Cipla Medpro South Africa

14 1Clinigen Group

15 1Etico Lifesciences

16 1Fresenius Kabi USA

17 1GENEYORK PHARMS

18 1Grupo Azevedos

19 1Hetero Drugs

20 1Hikma Pharmaceuticals

21 2Juno Pharmaceuticals Pty Ltd

22 1Lupin Ltd

23 1MERCK CANADA INC

24 1MSN Laboratories

25 2Medsurge Healthcare

26 10Merck & Co

27 1Navinta

28 1Piramal Enterprises Limited

29 1Polifarma

30 1Praxgen

31 1Qilu Pharmaceutical

32 2Reach Pharmaceuticals

33 1Sagent Pharmaceuticals

34 1Sakar Healthcare

35 1Steriscience

36 1Tarbis Farma Sl

37 2Tecnimede

38 1Teva Pharmaceutical Industries

39 1TherDose Pharma

40 2Viatris

41 1Zentiva

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info : RX

Registration Country : USA

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Packaging :

Approval Date : 2020-12-09

Application Number : 211160

Regulatory Info : RX

Registration Country : USA

Dr Reddy Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSupriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.

Regulatory Info :

Registration Country : India

Fosaprepitant

Brand Name :

Dosage Form : Injection

Dosage Strength : 150MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Supriya

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNaprod is a top player in Oncology & Anesthesia FDF through excellent innovation, discovery of new processes & high-quality production.

Regulatory Info :

Registration Country : India

Fosaprepitant Dimeglumine

Brand Name :

Dosage Form : Lyophilised Injection

Dosage Strength : 150MG/Vial

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Company Banner

04

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Packaging :

Approval Date : 2020-08-26

Application Number : 204025

Regulatory Info : DISCN

Registration Country : USA

blank

05

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Packaging :

Approval Date : 2019-09-05

Application Number : 205020

Regulatory Info : DISCN

Registration Country : USA

blank

06

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Packaging :

Approval Date : 2021-01-12

Application Number : 210625

Regulatory Info : RX

Registration Country : USA

blank

07

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Packaging :

Approval Date : 2019-09-05

Application Number : 211860

Regulatory Info : RX

Registration Country : USA

blank

08

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Packaging :

Approval Date : 2019-09-05

Application Number : 212309

Regulatory Info : RX

Registration Country : USA

blank

09

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Packaging :

Approval Date : 2020-12-08

Application Number : 203939

Regulatory Info : DISCN

Registration Country : USA

blank

10

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Packaging :

Approval Date : 2021-03-03

Application Number : 212143

Regulatory Info : RX

Registration Country : USA

blank

11

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Packaging :

Approval Date : 2016-06-09

Application Number : 206197

Regulatory Info : RX

Registration Country : USA

blank

12

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Packaging :

Approval Date : 2019-09-05

Application Number : 210689

Regulatory Info : DISCN

Registration Country : USA

blank

13

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : EMEND

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 115MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 2008-01-25

Application Number : 22023

Regulatory Info : DISCN

Registration Country : USA

blank

14

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : EMEND

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Packaging :

Approval Date : 2010-11-12

Application Number : 22023

Regulatory Info : RX

Registration Country : USA

blank

15

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Packaging :

Approval Date : 2019-09-05

Application Number : 209965

Regulatory Info : RX

Registration Country : USA

blank

16

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : UNKNOWN

Dosage Strength : UNKNOWN

Packaging :

Approval Date :

Application Number : 204845

Regulatory Info :

Registration Country : USA

blank

17

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Packaging :

Approval Date : 2019-09-05

Application Number : 210064

Regulatory Info : RX

Registration Country : USA

blank

18

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 115MG BASE/VIAL

Packaging :

Approval Date : 2019-09-05

Application Number : 204015

Regulatory Info : DISCN

Registration Country : USA

blank

19

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Packaging :

Approval Date : 2019-09-05

Application Number : 204015

Regulatory Info : RX

Registration Country : USA

blank

20

GENEYORK PHARMS

Country
AMWC Asia-TDAC
Not Confirmed
arrow

GENEYORK PHARMS

Country
arrow
AMWC Asia-TDAC
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Packaging :

Approval Date : 2019-09-05

Application Number : 211624

Regulatory Info : DISCN

Registration Country : USA

blank